Treatment of Relapsing HPV Diseases by Restored Function of Natural Killer Cells.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 34469647.
- Also identified by DOI 10.1056/NEJMoa2102715 and PMC identifier 8590529.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Human papillomavirus (HPV) infections underlie a wide spectrum of both benign and malignant epithelial diseases. In this report, we describe the case of a young man who had encephalitis caused by herpes simplex virus during adolescence and currently presented with multiple recurrent skin and mucosal lesions caused by HPV. The patient was found to have a pathogenic germline mutation in the X-linked interleukin-2 receptor subunit gamma gene (<i>IL2RG</i>), which was somatically reverted in T cells but not in natural killer (NK) cells. Allogeneic hematopoietic-cell transplantation led to restoration of NK cytotoxicity, with normalization of the skin microbiome and persistent remission of all HPV-related diseases. NK cytotoxicity appears to play a role in containing HPV colonization and the ensuing HPV-related hyperplastic or dysplastic lesions. (Funded by the National Institutes of Health and the Herbert Irving Comprehensive Cancer Center Flow Cytometry Shared Resources.).
Medical subject headings
- Germ-Line Mutation
- Hematopoietic Stem Cell Transplantation
- Killer Cells, Natural
- Papillomavirus Infections